IBSA USA
James Monte is a Specialty Pharmaceutical Sales Representative at IBSA USA, specializing in Endocrine and Pain Management since March 2023. Prior to this role, James served as a Field Services Engineer II at Intuitive, overseeing the maintenance and repair of over 50 robotic surgical systems. Experience also includes positions as an Infection Prevention and Patient Safety Consultant at Innovative Medical Systems and a Lap and Ligation Specialist at Symmetry Surgical, where James successfully introduced new products to several healthcare facilities. James's career began at Stryker as a Surgical ProCare Specialist, focusing on the repair and maintenance of surgical equipment. James holds a Bachelor of Arts in Communication from the State University of New York, and previously attended Arizona State University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.